Cas:124351-85-5 [(cycloheptylamino)-phosphonomethyl]phosphonic acid manufacturer & supplier

We serve Chemical Name:[(cycloheptylamino)-phosphonomethyl]phosphonic acid CAS:124351-85-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

[(cycloheptylamino)-phosphonomethyl]phosphonic acid

Chemical Name:[(cycloheptylamino)-phosphonomethyl]phosphonic acid
CAS.NO:124351-85-5
Synonyms:Incadronic acid
Molecular Formula:C8H19NO6P2
Molecular Weight:287.18700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:564.2ºC at 760mmHg
Density:1.48g/cm3
Index of Refraction:1.535
PSA:146.71000
Exact Mass:287.06900
LogP:1.32870

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Incadronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Incadronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Incadronic acid Use and application,Incadronic acid technical grade,usp/ep/jp grade.


Related News: Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. [(cycloheptylamino)-phosphonomethyl]phosphonic acid manufacturer Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. [(cycloheptylamino)-phosphonomethyl]phosphonic acid supplier Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. [(cycloheptylamino)-phosphonomethyl]phosphonic acid vendor The continuous acceleration of the industrial transfer process has provided a huge market space for the fine chemical intermediate industry. [(cycloheptylamino)-phosphonomethyl]phosphonic acid factory Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.